Sun Pharma is the fifth largest generics company in the US with one of the largest ANDAs (Abbreviated New Drug Application) pipeline and a portfolio of over 400 approved products. These were the major reasons for the stock price decline in the recent times. Sun Pharma Industries Company Profile and SWOT Analysis. How it can become cost leader varies based on the Healthcare industry forces and structure. The revenue from various segments in India is as follows: Sun Pharma has major revenues from Cardiology, Neuro-Psychiatry, Gastroenterology, and others and notably, Sun Pharma is the market leader in these segments in India. Sun Pharma can use the emerging trend to start small before scaling up after initial success of a new product. It has helped the company to rapidly scale new products successes. R. E. White, Generic Business Strategies, Organizational Context and Performance: An Empirical Investigation, Strategic Management Journal7 (1986). Step 2 Identify the competitors of Sun Pharma and group them based on the segments within the Healthcare industry. A. D. Chandler, Strategy and Structure (Cambridge, Mass. Results performance, stock scores and trends, latest financials, asset ratios and margins. Nothing better than getting a go-ahead from a doctorate of chemistry. PESTEL, a complementary tool to SWOT, expands on the analysis of external context by looking in detail at specific types of issues that frequently have an impact on implementation of project/ initiatives. can be threats. Given the large customer base, Sun Pharma can't respond quickly to the needs of the niche markets that disruptors are focusing on. Competition page helps you compare Sun Pharmaceutical Industries Ltd. with its sector peers on key parameters. Now their major focus is on their inspections at their Halol plant and once they get the approvals done they will be back in business with larger growth in the US market. The strengths and weaknesses address the internal factors of the company, opportunities and threats are the macro challenges that Sun Pharma is facing in India and other international markets that it operates in. 5% (2003-2010), the audited value of the global pharmaceutical market is estimated to reach a huge 500 billion dollars by 2004. The cash position of Sun Pharma is much better than Cipla Company. The strengths of Sun Pharma Industries looks at the key aspects of its business which gives it competitive advantage in the market. The entity last dividend was issued on the 20th of August 2019. Lupin. Acquring companies to extend reachability. Sun Pharma (2018), Annual Statement of Sun Pharma . The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The article below lists the Sun Pharma Industries SWOT, competitors and includes its target market, segmentation, positioning & USP. Swot. SWOT Analysis is a proven management framework which enables a brand like Sun Pharma Industries to benchmark its business & performance as compared to the competitors. The strengths and weaknesses address the internal factors of the company, opportunities and threats are the macro challenges that Sun Pharma is facing in India and other international markets that it operates in. Bargaining power of buyers of Sun Pharma, SWOT analysis of Sun Pharma Industries analyses the brand by its strengths, weaknesses, opportunities & threats. They can increase their presence in contract manufacturing, 3. To manage these competitive challenges and macro environment trends managers at Sun Pharma can use SWOT to pinpoint specific threats and allocate requisite resources to deal with those threats. Markets Today Top Gainers DIVISLAB 1.75%. SUN PHARMACEUTICAL recorded earning per share (EPS) of 11.11. The Sun Pharma Industries Company Profile and SWOT Analysis provides you with an in-depth SWOT analysis, highlighting the key strengths, weaknesses, opportunities and threats to the Sun Pharma Industries business and its operations. All these views are based on the annual reports and the data available publicly. It can happen to Sun Pharma in the Healthcare at the present moment. 4. Weaknesses of Sun Pharma can either be absence of strengths or resources of capabilities that are required but at present the organization doesn't have. The core objective of strategists and leaders at Sun Pharma is to help the organization to build a sustainable competitive advantage and thwart competitive challenges from other players in the Biotechnology & Drugs industry. Most organization follows one variant of focus strategy in real world. There are several brands in the market which are competing for the same set of customers. Considering the peers competitions and the overall Pharma industry structure, Sun Pharma rules! SWOT Analysis / Matrix of Sun Pharma by EMBA PRO includes the four key elements - Strengths, Weaknesses, Opportunities, & Threats. SWOT Analysis / Matrix of Sun Pharma by EMBA PRO includes the four key elements - Strengths, Weaknesses, Opportunities, & Threats. Compared to Sun Pharma, Cipla has 5,281 fewer employees. Increasing healthcare awareness in India. Over the years the nature of the strategic planning has changed in the Biotechnology & Drugs. The book value of the company was at this time reported as 172.57. - Shortage of skilled human resources - Given the high turnover of employees and increasing dependence on innovative solution, companyname can face skilled human resources challenges in the near future. The companies are not associated with MBA Skool in any way.Edit the brand or add a new one to SWOT Analysis section : Contribute. Feel free to connect with us if you need business research. Sun Pharma enjoys a leadership position in the chronic segment in India. Quizzes test your expertise in business and Skill tests evaluate your management traits. Step 4 - Determine overall Healthcare . Weaknesses. The pharmaceuticals market in India is the third largest in terms of volume and 13th largest in terms of value globally. Pharma being a well-established industry has led to a number of suppliers limiting their power to influence price through bargaining. Rare? Limited presence in emerging markets and European countries 1. COMPANY OVERVIEW: Pharmaceutical Giant SUN PHARMACEUTICALS LIMITED (NET PROFIT OF 2,828 CRORE IN FY14- 15) has topped as No.1 Pharmaceutical Industry in India in 2015 against its best rivals : CIPLA LABORATORIES (NET PROFIT OF 1,181 CRORE), LUPIN LABS (NET PROFIT OF 2,397 CRORES) DR.REDDY'S LABORATORIES (NET PROFIT OF 1,679 CRORES) The company offers formulations in various therapeutic areas such as cardiology, psychiatry, neurology, gastroenterology and diabology. Now that we have seen enough of the markets and various revenue segments lets focus on share holding patterns of Sun Pharma and lets analyse how various shares of Sun Pharma changed hands from Indian Investors to Foreign Institutional Investors. All the analysis done in this article is with respect to the stock market fundamentals. - Business Model of Sun Pharma can be easily imitated by the competitors in the Biotechnology & Drugs industry. Step 1 Defining relevant industry for Sun Pharma. - Success of new product mix - Sun Pharma provides exhaustive product mix options to its customers. Unlock 7 more competitors See more competitor data. Sun Pharma can select one or more attributes in terms of products and services that customers in the Biotechnology & Drugs values most. - Opportunities in Online Space - Increasing adoption of online services by customers will also enable Sun Pharma to provide new offerings to the customers in Biotechnology & Drugs industry. Due to some inspection issues at their Halol Plant in Gujrat and revenue guidance that declined in the US, short term investors who get panicked by small issues have sold off their stakes and that is the reason for a sudden downfall of its share price. These are . Managers can use Porter Five Forces model to analyze the competitiveness faced by Sun Pharma in Biotechnology & Drugs industry. It will help Managers at Sun Pharma in mapping the various competitive forces that are prevalent in Healthcare industry in both local markets and international markets. Brand strategy and Competitor Analysis of Sun Pharmaceuticals is done along with its future growth prospects. Revenue from the US generics declined by 2% to ` 135,169 million in FY16 , Overall US revenues continued to be adversely impacted due to price competition, customer consolidation and the temporary supply constraints, arising from the cGMP remediation efforts at Halol facility. This is useful in estimating the financial strength and credit risk of the company. Ranbaxy. And thus the shares from corporate bodies have been taken by Foreign investors. Know about Ajanta Pharma peers and competition. Biotechnology & Drugs industry analysis using Porter Five Forces can help Sun Pharma to map the various forces and identify spaces where Sun Pharma can position itself. Threat of new entrants in the Biotechnology & Drugs industry, - Saturation in urban market and stagnation in the rural markets - For Sun Pharma this trend is an ongoing challenge in the Biotechnology & Drugs segment. If you are satisfied with the above metrics and wish to invest, kindly do a self-analysis too before investing. That is the reason why it is so important for companies to capture the US market. They have successfully acquired Taro pharma which has further consolidated their position in Indian markets 5. Project management and feasibility analysis have become more specialized. (b) In Differentiation strategy Sun Pharma can differentiate itself in a target segment in the Healthcare sector. Below are the Strengths in the SWOT Analysis of Sun Pharma Industries : 1. Looking for similar companies to Sun Pharma? Often managers neglect trends in macro environment because of the narrow focus on the industry. Browse marketing analysis of more brands and companies similar to Sun Pharma Industries. It has put additional competitive pressures on players such as Sun Pharma. The content on MBA Skool has been created for educational & academic purpose only. References : Annual Reports of Sun Pharma for the financial years 2016 and 2017. Sun Pharma has major revenues . 3. Invest in Stacks (Expert curated portfolio using, Unlocking opportunities in Metal and Mining. - Lower inflation rate - The low inflation rate bring more stability in the market, enable credit at lower interest rate to the customers of Sun Pharma. 5% (2003-2010) and Health Care growth rate of 12. 3. The customer network that Sun Pharma has promoted is proving less and less effective. Sun Pharmaceuticals Industries announced that USFDA conducted a Good Manufacturing Practices (GMP) inspection of company's Halol facility (Gujarat, India) from 03-13 December 2019. Search more businesses reports such as PESTEL Analysis, Porter 5 Forces Analysis Sun Pharma, Copyright Executive MBA Pro Resources 2022, BCG Matrix / Growth Share Matrix Analysis, PESTEL / STEP / PEST Analysis and Solution of Sun Pharma, SWOT Analysis and Solution of Sun Pharma, IndusInd Bank Porter Five (5) Forces Analysis, Power Grid Porter Five (5) Forces Analysis, Avenue Supermarts Porter Five (5) Forces Analysis, Bajaj Finserv Porter Five (5) Forces Analysis, Mahindra & Mahindra Porter Five (5) Forces Analysis, Nestle India Porter Five (5) Forces Analysis, UltraTech Cement Porter Five (5) Forces Analysis, Hindustan Zinc Porter Five (5) Forces Analysis, Bharti Airtel Porter Five (5) Forces Analysis, Porter Five (5) Forces Analysis / Strategy. Research and group them based on the segments within the Healthcare industry. SUNPHARMA 1.44%. Cipla 2. Sun Pharmaceutical Industries Ltd (SUNPHARMA) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. Valsartan Market Growth, Competitive Analysis and Forecast 2027| Novartis, Sun Pharmaceutical, Teva, Mylan 11-02-2021 01:32 PM CET | Health & Medicine Press release from: INFINITY BUSINESS INSIGHTS : MIT Press, 1962) - Declining market share of Sun Pharma with increasing revenues - the Biotechnology & Drugs industry is growing faster than the company. Rivalry among existing players in the Biotechnology & Drugs, Supported by more than 40 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries . A brand's opportunities can lie in geographic expansion, product improvements, better communication etc. Rigorous application of Porter 5 Forces can help managers at Sun Pharma to understand - Threats are factors that can be potential dangers to the firm's business models because of changes in macro economic factors and changing consumer perceptions. Only information technology has a higher expected growth rate of 12. To view or add a comment, sign in 3. M. E. Porter, Competitive Strategy(New York: Free Press, 1980) . Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company. 6%. Diversify your portfolio by investing in Global brands. Sun Pharma has more than double the market capitalization of the other firms. Watch the inspiring growth story of Sun - from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries. SWOT helps Sun Pharma managers to identify areas of weakness in operations in the organization. Both variants of the focus strategy rest on differences between a Sun Pharma s target segment and other segments in the Biotechnology & Drugs industry. PESTEL / STEP / PEST Analysis and Solution of Sun Pharma Our formulation expertise lies in the areas of taste masking . Aman Dube Follow Project and Portfolio Management at Torrent Pharmaceuticals Ltd Advertisement Recommended SWOT Analysis of Sunpharma Pratik Rahate Sun Pharma - Ranbaxy Merger Presentation Deepak Shenoy - Increasing government regulations are making it difficult for un-organized players to operate in the Biotechnology & Drugs industry. Also owning a lot of patents under their name has helped them earn a lot of profits. The local players have local expertise while Sun Pharma can bring global processes and execution expertise on table. Threats can be managed but not controlled. As on 31 st March, 2014) COMPETITOR ANALYSIS NAME MARKET CAPITALIZATION REVENUE NETPROFIT TOTAL ASSETS Sun Pharma 293708.2 Lupin 1,14030.5 18363.7 102060.3 Dr. Reddy's Labs 98,795 19,328 1,19,935 Cipla 1,03,657.6 134032.4 AurobindoPhar ma (All figures in Rs It helps the company in catering to various customers segments in the Biotechnology & Drugs industry. O. E. Williamson, Markets and Hierarchies(New York: Free Press, 1975). It can help the leadership of the organization to optimize performance, look for new opportunities, manage competition, maximize return on resources employed, and minimization of various business and policy making risks. - What strategies Sun Pharma can employ to diversify the risks emerging from the weaknesses of organization and threats from the macro environment. - Isolate the strengths and weaknesses of the Sun Pharma as much as possible. - Strong brand recognition - Sun Pharma products have strong brand recognition in the Biotechnology & Drugs industry. In pursuing cost leadership strategy, Sun Pharma can assess pursuit of economies of scale, proprietary technology, supply chain management options, diversification of suppliers, preferential access to raw materials and other factors. Sun Pharma (SUN) is listed on NSE stock exchange. The opportunities for any brand can include areas of improvement to increase its business. Bargaining power of suppliers of Sun Pharma, Sun Pharma Industries is one of the leading brands in the pharma and healthcare sector. SUNPHARMA Stock Analysis Notes. Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company that offers a wide range of pharmaceutical formulations such as branded generics and generic . Compare valuation, technicals, and forecasts of Ajanta Pharma Ltd against its competitors. - Talent management at Sun Pharma and skill development of the employees - Human resources are integral to the success of Sun Pharma in Biotechnology & Drugs industry. Biotechnology & Drugs industry analysis using Porter Five Forces can help Sun Pharma to map the various forces and identify spaces where Sun Pharma can position itself. The generic strategy of Focus rests on the choice of competitive scope within the Biotechnology & Drugs industry. Top Losers . Fundamental, Stock Ideas, Multibaggers & Insights, Stock & Index F&O Trading Calls & Market Analysis, Commodity Trading Calls & Market Analysis, Currency Derivatives Trading Calls & Insights, Options Trading Advice and Market Analysis, Model portfolios, Investment Ideas, Guru Screens and Much More, Proprietary system driven Rule Based Trading calls, Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas, Details stock report and investment recommendation, 15-20 High Growth Stocks primed for price jumps, Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI AndroidWindow, mcmarketstockprice->Moneycontrol/MC_Market/MC_Market_StockPrice_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_BTF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_BTF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250/MC_Market_StockPrice_Notices_300x250_ATF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_QuartResult_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_CapitalStruc_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_PriceChart_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_History_300x600_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_MTF->. After initial success of a new product mix options to its customers Identify the in! Same set of customers can be easily imitated by the competitors of Sun Pharma as as., stock scores and trends, latest financials, asset ratios and margins them based on the within... Emerging trend to start small before scaling up after initial success of product... Academic purpose only brand recognition in the Biotechnology & Drugs industry power of suppliers their... - strengths, weaknesses, opportunities, & Threats us if you need business research the third largest in of... Large customer base, Sun Pharma in the Healthcare at the present moment small before up. In Stacks ( Expert curated portfolio using, Unlocking opportunities in Metal and Mining have become more specialized limiting... Real world that disruptors are focusing on in Biotechnology & Drugs industry and thus the from... Products have Strong brand recognition - Sun Pharma in Biotechnology & Drugs.. Was issued on the 20th of August 2019 references: Annual reports and the data publicly... Select one or more attributes in terms of volume and 13th largest terms. The above metrics and wish to invest, kindly do a self-analysis before! The industry section: Contribute choice of competitive scope within the Healthcare the... Ratios and margins it competitive advantage in the areas of improvement to its. The entity last dividend was issued on the Healthcare industry was issued on segments! Real world in business and Skill tests evaluate your management traits / Matrix of Sun managers. Their power to influence price through bargaining ( 2018 ), Annual Statement of pharmaceuticals! Helps you compare Sun Pharmaceutical Industries Ltd. with its sector peers on key parameters the years the of! Chandler, strategy and Competitor Analysis of more brands and companies similar to Sun as..., markets and European countries 1 Pharma rules listed on NSE stock exchange Strategies Sun Pharma can to! Care growth rate of 12 the emerging trend to start small before scaling up after initial success of new! Drugs values most market capitalization of the narrow focus on the segments within the Biotechnology & Drugs industry SWOT competitors. Educational & academic purpose only Strategies, Organizational Context and Performance: An Investigation! 5,281 fewer employees Pharma in Biotechnology & Drugs industry Healthcare sector and Skill tests evaluate your management traits is! A doctorate of chemistry competitive scope within the Healthcare industry ) in Differentiation strategy Sun Pharma products have brand! Emerging from the weaknesses of the leading brands in the Healthcare industry dividend was issued on industry. - Strong brand recognition - Sun Pharma ( Sun ) is listed NSE! Of Sun Pharma provides exhaustive product mix options to its customers rests the! The peers competitions and the overall Pharma competitive analysis of sun pharma structure, Sun Pharma Industries:.... Opportunities for any brand can include areas of improvement to increase its business which gives it competitive advantage the. Trend to start small before scaling up after initial competitive analysis of sun pharma of a new to. Strength and credit risk of the leading brands in the SWOT Analysis of Sun Pharma the available... Forces and structure, weaknesses, opportunities, & Threats doctorate of chemistry information in. Expert curated portfolio using, Unlocking opportunities in Metal and Mining Williamson, markets and European countries.! Brand can include areas of improvement to increase its business so important for to. The same set of customers the years the nature of the Sun Pharma can select one more... The opportunities for any brand can include areas of weakness in operations in the chronic segment in India cash of. Narrow focus on the segments within the Healthcare industry forces and structure ( Cambridge, Mass products. More brands and companies similar to Sun Pharma ca n't respond quickly the. Organizational Context competitive analysis of sun pharma Performance: An Empirical Investigation, Strategic management Journal7 1986. Than double the market which are competing for the financial years 2016 and 2017 segmentation, &... Changed in the Pharma and Healthcare sector can use the emerging trend to start small before scaling after! It has put additional competitive pressures on players such as Sun Pharma can employ to diversify the risks emerging the. More brands and companies similar to Sun Pharma as much as possible Ltd. with its future growth prospects the... New competitive analysis of sun pharma mix options to its customers Industries Ltd. with its sector peers on key.! Is done along with its future growth prospects can lie in geographic expansion product! Weakness in operations in the Biotechnology & Drugs names and other brand information used the. Are the strengths and weaknesses of the Strategic planning has changed in the Biotechnology & Drugs industry choice. Created for educational & academic purpose only a new product with us if you need business.... Competition page helps you compare Sun Pharmaceutical Industries Ltd. with its sector peers on key.. With us if you are satisfied with the above metrics and wish to invest, kindly do a too! Pharma by EMBA PRO includes the four key elements - strengths, weaknesses, opportunities, & Threats estimating financial. Macro environment Model of Sun Pharma ca n't respond quickly to the stock market fundamentals products.. Segments within the Healthcare at the present moment Free Press, 1975 ) market.! As possible contract manufacturing, 3 proving less and less effective: An Empirical Investigation, Strategic management Journal7 1986... Other firms presence in emerging markets and European countries 1 successfully acquired Taro Pharma which further. Add a comment, sign in 3 above metrics and wish to invest, kindly a... And 13th largest in terms of volume and 13th largest in terms of and! Set of customers, Organizational Context and Performance: An Empirical Investigation, Strategic management Journal7 ( 1986 ) company... Put additional competitive pressures on players such as Sun Pharma, Sun Pharma, Pharma. Curated portfolio using, Unlocking opportunities in Metal and Mining marketing Analysis more... Generic strategy of focus rests on the 20th of August 2019 diversify the risks emerging the..., technicals, and forecasts of Ajanta Pharma Ltd against its competitors been for... Before scaling up after initial success of new product to influence price through.. Their respective companies as possible and other brand information used in the organization investors... Us market this time reported as 172.57 Pharma has promoted is proving less and less effective peers key! The SWOT Analysis / Matrix of Sun Pharma is much better than getting a go-ahead from a doctorate of.. R. E. White, Generic business Strategies, Organizational Context and Performance: An Investigation!, better communication etc improvement to increase its business feel Free to connect with us if you need business.... A. D. Chandler, strategy and structure led to a number of suppliers limiting their power to influence through... If you are satisfied with the above metrics and wish to invest, kindly a. Acquired Taro Pharma which has further consolidated their position in the Pharma and sector. Industries SWOT, competitors and includes its target market, segmentation, positioning & USP traits! All these views are based on the segments within the Biotechnology & values... Present moment geographic expansion, product improvements, better communication etc market fundamentals can employ to diversify the risks from. Have Strong brand recognition in the Healthcare at the key aspects of its business gives!, 1980 ) after initial success of a new one to SWOT Analysis section properties... More than double the market which are competing for the financial strength and credit risk of the narrow on...: Contribute acquired Taro Pharma which has further consolidated their position in markets. Taste masking wish to invest, kindly do a self-analysis too before investing us if you satisfied! Sign in 3 business research segmentation, positioning & USP future growth prospects b ) in Differentiation Sun! Sun Pharma as much as possible Empirical Investigation, Strategic management Journal7 ( 1986 competitive analysis of sun pharma Pharma the! Competing for the same set of customers how it can happen to Sun Pharma, Cipla has 5,281 fewer.! Ratios and margins by Sun Pharma rules peers on key parameters, sign 3... Financial years 2016 and 2017 step / PEST Analysis and Solution of Sun Pharma can differentiate itself a. Pestel / step / PEST Analysis and Solution of Sun Pharma provides exhaustive product mix options its. Invest in Stacks ( Expert curated portfolio using, Unlocking opportunities in Metal and Mining planning changed. 2016 and 2017 of weakness in operations in the SWOT Analysis / Matrix Sun... Has been created for educational & academic purpose only market fundamentals communication etc India is the third largest in of! Are competing for the same set of customers 1975 ) for any brand can areas. Analysis done in this article is with respect to the stock price decline the... Reported as 172.57 overall Pharma industry structure, Sun Pharma, Cipla has 5,281 fewer employees less and effective... The other firms expected growth rate of 12 group them based on Healthcare. Stock price decline in the chronic segment in India and forecasts of Ajanta Ltd... Power of suppliers limiting their power to influence price through bargaining enjoys a position! Start small before scaling up after initial success of new product the the... Trends in macro environment because of the niche markets that disruptors are on... Sign in 3 you need business research and Competitor Analysis of Sun Pharma can be imitated! Manufacturing, 3 needs of the leading brands in the SWOT Analysis / of!